Abbott, Exact Sciences
Digest more
Abbott Laboratories $21 billion deal to acquire cancer test maker Exact Sciences could bolster the company’s diagnostic ...
Stocks were falling Thursday, following Nvidia’s turn lower—putting the market on track for its biggest blown gain since ...
Shares of cancer diagnostic specialist Exact Sciences (NASDAQ: EXAS) rallied 50.7% this week through Thursday at 3:30 PM EDT.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results